Risk Factors for Perioperative Complications, Treatment Outcomes and Aggressive Behavior of the Tumor in Patients with Pheochromocytoma
- PMID: 39620189
- PMCID: PMC11604364
- DOI: 10.15605/jafes.039.02.07
Risk Factors for Perioperative Complications, Treatment Outcomes and Aggressive Behavior of the Tumor in Patients with Pheochromocytoma
Abstract
Introduction: Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells of the adrenal gland. Surgery is the only curative treatment with a high biochemical cure rate, low mortality and high risk of perioperative complications.
Objectives: To study the demographic characteristics of patients with pheochromocytoma and to identify the risk factors for perioperative complications, treatment outcomes, and aggressive behavior of the tumor.
Methodology: We retrospectively studied the data of pheochromocytoma patients registered from 2012 to 2022.
Results: In our study, a total of 30 patients with pheochromocytoma were included. The mean age of presentation was 35 ± 12.8 years. Fifty-six percent were females, and the sex ratio was 1.3:1. Pheochromocytoma spells (60%) was the most common complaint, followed by abdominal pain (53%), orthostatic complaints (10%) and incidentalomas (6%). The baseline mean 24-hour urinary total metanephrines was 2963.7 ± 2658 mcg/24 hours, and the mean tumor size was 7.3 ± 0.53 cm. Forty-three percent of patients underwent laparoscopic adrenalectomy, while the rest underwent open surgery. The mean Pheochromocytoma of Adrenal gland Scaled Score(PASS) was 3.41 ± 0.28, and 23% had a high risk for malignancy. Among perioperative complications, hypertensive crisis (17%) was the most common, followed by postoperative hypotension (13%), hypoglycemia (3%) and right-sided pneumothorax (3%). These patients with complications had higher metanephrine levels (5490 vs. 1880 mcg/24 hours, p = 0.001). Blood pressure normalized in 50%, and this was associated with male sex, younger age (29.5 vs. 40 years, p = 0.03), higher metanephrines (4619 vs. 1855 mcg/24 hours, p = 0.001) and smaller tumors (5.91 vs. 8.61 cm, p = 0.046). PASS score greater than or equal to 4 was associated with higher metanephrine levels (5104 vs. 2312 mcg/24 hours, p = 0.021) and larger tumors (9.28 vs. 6.68 cm, p = 0.024). Biochemical cure rate was achieved in 76% of patients after surgery and was associated with older age (37.7 years vs. 27.7 years, p = 0.047) and absence of pheochromocytoma spells (100% vs. 61%, p = 0.014).
Conclusion: Young age, smaller tumor size and higher metanephrine concentrations were associated with normalization of blood pressure post-surgery. On the other hand, older patients and those without pheochromocytoma spells had better biochemical cure rates. Patients with higher baseline metanephrine levels had increased perioperative complications. More aggressive tumor behavior was associated with higher metanephrine levels and larger tumors. Sex, baseline blood pressure and mode of surgery did not have any influence on treatment outcomes.
Keywords: PASS score; Pheochromocytoma spells; metanephrines; perioperative complications.
© 2024 Journal of the ASEAN Federation of Endocrine Societies.
Conflict of interest statement
The authors declared no conflict of interest
Similar articles
-
Predictors of Hypotension after Adrenalectomy for Pheochromocytoma.Acta Med Okayama. 2021 Jun;75(3):345-349. doi: 10.18926/AMO/62229. Acta Med Okayama. 2021. PMID: 34176938
-
Risk factors for intraoperative complications in pheochromocytomas.Endocr Relat Cancer. 2021 Sep 8;28(11):695-703. doi: 10.1530/ERC-21-0230. Endocr Relat Cancer. 2021. PMID: 34379605
-
Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma.Surgery. 2016 Mar;159(3):763-70. doi: 10.1016/j.surg.2015.09.016. Epub 2015 Oct 21. Surgery. 2016. PMID: 26477475
-
Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.Horm Metab Res. 2012 May;44(5):385-9. doi: 10.1055/s-0031-1301339. Epub 2012 Feb 20. Horm Metab Res. 2012. PMID: 22351478 Review.
-
Incidental adrenal pheochromocytoma. Report on 5 operated patients and update of the literature.Arch Ital Urol Androl. 2003 Dec;75(4):217-25. Arch Ital Urol Androl. 2003. PMID: 15005498 Review.
Cited by
-
Sex differences in management and outcomes in pheochromocytomas and paragangliomas.Front Endocrinol (Lausanne). 2025 Jun 16;16:1597908. doi: 10.3389/fendo.2025.1597908. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40589516 Free PMC article.
References
-
- Pacak K, Taieb D, Lenders JWM, et al. . Pheochromocytoma In: Robertson RP, ed. DeGroot’s textbook of Endocrinology, 8th ed. Elsevier; 2021.
-
- Lenders JW, Duh QY, Eisenhofer G, et al. ; Endocrine Society . Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42. PMID: 24893135. DOI: 10.1210/jc.2014-1498. Erratum in: J Clin Endocrinol Metab. 2023;108(5):e200. PMID: 24893135. DOI: 10.1210/clinem/dgad064. - DOI - PubMed
-
- Lenders JWM, Kerstens MN, Amar L, et al. . Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: A position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38(8):1443–56. PMID: 32412940 PMCID: DOI: 10.1097/HJH.0000000000002438. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical